PureTech Health PLC banner

Intrinsic Value

The intrinsic value of PureTech Health PLC (0VQ) under the Base Case is 1.45 EUR per share. Compared with the current market price of 1.45 EUR, the stock appears Fairly Valued .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

0VQ Intrinsic Value
€1.45
Fairly Valued
Intrinsic Value
Price €1.45
Alert me when 0VQ is below its intrinsic value
Today €1.16 · 20.1% below the current price

0VQ is cheaper than usual. Its valuation was this low or lower on just 21% of days in the past 4 years.

Alternatives to 0VQ

Fundamental Analysis

What PureTech Health Does

Biotechnology Health Care

PureTech Health is a biotechnology company that builds and develops new medicines for hard-to-treat diseases. It starts with scientific ideas around biology and turns them into drug programs, often by creating or backing separate portfolio companies to carry the work forward. Its value comes from discovering promising therapies, advancing them through research and clinical testing, and partnering or spinning them out when they reach the right stage.

Headquarters
United States of America US
Employees
61
IPO date
Jun 19, 2015
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
PureTech Health PLC

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one 0VQ stock?

The intrinsic value for PureTech Health PLC (0VQ) under the Base Case is 1.45 EUR.

Is 0VQ stock undervalued or overvalued?

Compared with the current market price of 1.45 EUR, the stock appears Fairly Valued .

Back to Top